If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXp Factory Regulatory News (XPF)

Share Price Information for Xp Factory (XPF)

Share Price is delayed by 15 minutes
Get Live Data
19.00    0.00 (0.00%)
Bid:
18.50
Ask:
19.50
Spread: 1.00 (5.405%)
Market Cap: £33.37m
XPF Live PriceLast checked at - London Stock Exchange

Intraday Xp Factory Share Chart

Conversion of CLNs and TVRs

11 Jan 2022 07:00

RNS Number : 9839X
XP Factory PLC
11 January 2022
 

11 January 2022

XP Factory Plc

("XP Factory", the "Company" or the "Group")

Conversion of Convertible Loan Notes

and

Total voting rights

 

XP Factory announces that it has received a Noteholder Notice of Conversion in relation to all of its outstanding Convertible Loan Notes ("Notes") together with all accrued interest. £340,000 Notes were issued by the Company on 2 July 2020 as part of the £4.3 million fundraising completed at that time and accrue interest at 10 per cent. per annum. In accordance with the terms of the Notes, the conversion price is 9p per share and the conversion of the principal amount of the Notes, together with accrued interest, will result in the issue by the Company of 4,378,082 new XP Factory shares ("New Ordinary Shares") on 2 February 2022.

Application will be made for admission of the New Ordinary Shares to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings in the Ordinary Shares will commence at 8.00 a.m. on 3 February 2022.

 Total Voting Rights

Upon Admission, the Company's total issued share capital will be 150,383,180 Ordinary Shares and the Company does not hold any shares in treasury. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

XP Factory Plc

https://www.xpfactory.com/

Richard Harpham (Chief Executive Officer)

Graham Bird (Chief Financial Officer)

Kam Bansil (Investor Relations)

 

+44 (0) 20 7846 3322

Shore Capital, NOMAD and Broker

https://www.shorecap.co.uk/

Tom Griffiths/David Coaten (Corporate Advisory)

 

 

+44 (0) 20 7408 4050

IFC Advisory - Financial PR

https://www.investor-focus.co.uk/

Graham Herring

Florence Chandler

 

+44 (0) 20 3934 6630

Notes to Editors:

About XP Factory plc

 

The XP Factory Group is one of the UK's pre-eminent experiential leisure businesses which currently operates two fast growing leisure brands. Escape Hunt is a global leader in providing escape-the-room experiences delivered through a network of owner-operated sites in the UK, an international network of franchised outlets in five continents, and through digitally delivered games which can be played remotely.

Boom Battle Bar is a fast-growing network of owner-operated and franchise sites in the UK that combine competitive socialising activities with themed cocktails, drinks and street food in a high energy, fun setting. Activities include a range of games such as augmented reality darts, Bavarian axe throwing, 'crazier golf', shuffleboard and others. The Group's products enjoy premium customer ratings and cater for leisure or teambuilding, in small groups or large, and are suitable for consumers, businesses and other organisations. The Company has a strategy to expand the network in the UK and internationally, creating high quality games and experiences delivered through multiple formats and which can incorporate branded IP content. (https://xpfactory.com/)

 

Facebook: EscapeHuntUK BoomBattleBar

Twitter: @EscapeHuntUK @boombattlebar

Instagram: @escapehuntuk @boombattlebar

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONURABRUAUAAAR
Date   Source Headline
12th Jun 20262:09 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector Share and Option Award
14th May 20264:37 pmRNSHolding(s) in Company
13th May 20266:13 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSFY26 Trading Update
29th Apr 20267:00 amRNSAppointment of Broker, NOMAD & Financial Adviser
14th Apr 20263:36 pmRNSDirector/PDMR Shareholding
13th Apr 20261:46 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSIssue of Shares and Total Voting Rights
19th Mar 20268:49 amRNSHolding(s) in Company
16th Mar 20266:08 pmRNSHolding(s) in Company
27th Feb 202610:51 amRNSHolding(s) in Company
20th Feb 202612:36 pmRNSDirector/PDMR Shareholding
3rd Feb 20262:30 pmRNSHolding(s) in Company
2nd Feb 20267:01 amRNSAppointment of Non-executive Chairman
2nd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSHolding(s) in Company
16th Jan 202611:05 amRNSHolding(s) in Company
13th Jan 20264:32 pmRNSDirector/PDMR Shareholding
12th Dec 20251:51 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSInterim Results
14th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Oct 20254:49 pmRNSDirector/PDMR Shareholding
29th Sep 20254:18 pmRNSResult of AGM
29th Sep 20257:00 amRNSDirectorate Change
15th Sep 202511:07 amRNSDirector/PDMR Shareholding
5th Sep 202510:38 amRNSHolding(s) in Company
5th Sep 20259:14 amRNSPosting of Annual Report and Notice of AGM
1st Sep 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Sep 20257:00 amRNSPreliminary Unaudited Final Results
13th Aug 20252:46 pmRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSTrading Update and Notice of Results
16th Jul 202512:50 pmRNSDirector/PDMR Shareholding
16th Jul 202512:44 pmRNSDirector/PDMR Shareholding
13th Jun 20251:45 pmRNSDirector/PDMR Shareholding
14th May 20256:00 pmRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSFY25 Trading Update
16th Apr 202510:00 amRNSDirector/PDMR Shareholding
4th Apr 202512:00 pmRNSDirector/PDMR Shareholding
1st Apr 20253:33 pmRNSShare Capital Reduction Effective
25th Mar 20254:00 pmRNSCapital Reduction Update
14th Mar 20252:30 pmRNSDirector/PDMR Shareholding
5th Mar 20255:09 pmRNSResult of General Meeting
5th Mar 20257:00 amRNSCapital Markets Day Event
17th Feb 20257:00 amRNSReduction of Capital, Circular & Notice of GM
13th Feb 202510:45 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSNotice of Capital Markets Day Event
14th Jan 20252:12 pmRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update
16th Dec 202412:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.